208
A SIMPLE blood sample to detect the presence of 50 tumors, even before symptoms occur, when treatments are most likely to be successful. And to identify, with a high degree of precision, even the affected organ of the disease. The test we are talking about is the result of the last phase of the Circulating Cell-free Genome Atlas (or CCGA, an investigation
.